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Background: Rapid diagnostic tests (RDT) for malaria have been demonstrated to be effective and they should
replace microscopy in certain areas.
Method: The cost-effectiveness of five RDT and thick smear microscopy was estimated and compared. Data were
collected on Brazilian Extra-Amazon Region. Data sources included the National Malaria Control Programme of the
Ministry of Health, the National Healthcare System reimbursement table, laboratory suppliers and scientific literature.
The perspective was that of the Brazilian public health system, the analytical horizon was from the start of fever
until the diagnostic results provided to patient and the temporal reference was that of year 2010. Two costing
methods were produced, based on exclusive-use microscopy or shared-use microscopy. The results were expressed
in costs per adequately diagnosed cases in 2010 U.S. dollars. One-way sensitivity analysis was performed
considering key model parameters.
Results: In the cost-effectiveness analysis with exclusive-use microscopy, the RDT CareStartTM was the most
cost-effective diagnostic strategy. Microscopy was the most expensive and most effective, with an additional case
adequately diagnosed by microscopy costing US$ 35,550.00 in relation to CareStartTM. In opposite, in the
cost-effectiveness analysis with shared-use microscopy, the thick smear was extremely cost-effective. Introducing
into the analytic model with shared-use microscopy a probability for individual access to the diagnosis, assuming a
probability of 100% of access for a public health system user to any RDT and, hypothetically, of 85% of access to
microscopy, this test saw its effectiveness reduced and was dominated by the RDT CareStartTM.
Conclusion: The analysis of cost-effectiveness of malaria diagnosis technologies in the Brazilian Extra-Amazon
Region depends on the exclusive or shared use of the microscopy. Following the assumptions of this study,
shared-use microscopy would be the most cost-effective strategy of the six technologies evaluated. However, if
used exclusively for diagnosing malaria, microscopy would be the worst use of resources. Microscopy would not be
the most cost-effective strategy, even when structure is shared with other programmes, when the probability of a
patient having access to it was reduced. Under these circumstances, the RDT CareStartTM would be the most
cost-effective strategy.
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Brazil presents two quite distinct epidemiological situa-
tions with regard to malaria transmission. The Amazon
Region – which includes nine states of the federation –
is an area with high endemicity that annually registers
99.8% of the country’s malaria cases, with an Annual
Parasitic Incidence (API) of more than 49.9 cases per
1,000 inhabitants in some transmission areas [1-3]. The
area known as the Extra-Amazon Region – composed of
17 states and the Federal District – registers more than
1,000 new cases per year, including imported and
autochthonous ones [4]. In this area, in the year 2010,
1,263 cases of malaria were registered, with 901 (71%) of
them caused by Plasmodium vivax [4]. The states of São
Paulo (SP), Espírito Santo (ES), Minas Gerais (MG),
Goiás (GO) and the Federal District (DF) notified 50% of
the cases registered in 2010 in the whole Extra-Amazon
Region; the cases dealt with in this area are mostly
imported from Amazonia or from countries with malaria
transmission, such as African countries and Paraguay,
but there are some autochthonous cases, mainly from
São Paulo and Espírito Santo states [4].
Due to the low incidence of malaria in the Extra-
Amazon Region, it is a great challenge to diagnose it,
requiring doctors trained in diagnosis of suspected cases
and in the opportune treatment of these, as well as
laboratories ready to make early and accurate specific
diagnostic. As the Extra-Amazon area receives imported
cases, especially from African countries, opportune diag-
nostic is essential for the appropriate management of the
disease, in order to prevent severe manifestations of
malaria and deaths caused, especially, by Plasmodium
falciparum.
Microscopy by the thick smear technique is the most
widely used diagnostic method, including in the Extra-
Amazon area. It is a low-cost test that, however, demands
experienced professionals to carry it out and read the
results. Variations in the execution technique and loss of
slide quality can compromise the accuracy of the test,
which is considered the gold standard for malaria [5]. In
the Extra-Amazon Region, diagnosis by microscopy is
carried out in centers of reference for the test, situated in
all the state capitals and in towns in areas where there
have, historically, been more cases recorded. Suspected
cases are sent to these reference centers for diagnosis,
and these centers are sometimes not where the patients
live. To have easy access to diagnostic of malaria is a
relevant factor for the economic costs of the disease.
Macaluley [6] studied a strategy of aggressive active case
detection; despite being more expensive, this strategy
potentially can be clearly worthwhile, especially be-
cause of the diagnostic of asymptomatic malaria and
the expanded access to diagnosis in populations living
in areas of malaria transmission risk. Pang [7] studieda community-based programme incorporating dipstick
tests for malaria management, which improved the access
to diagnosis in remote areas, concluding that it could
have economic advantages.
Rapid Immunochromatographic Diagnostic Tests
(RDTs) to diagnose malaria were developed in the 1990s.
These are tests that detect Plasmodium antigens in the
peripheral blood, by means of a finger-prick, and furnish
the diagnosis in 15 minutes. They do not require labora-
tory structure or highly experienced professionals for
their execution [8], but their high cost compared to the
thick smear test is one of their drawbacks for use on a
large scale. RDTs have been recommended by the World
Health Organization (WHO) and by the Brazilian Ministry
of Health for use in remote areas [8-10], where there are
no laboratories for microscopy available; in Brazil, RDTs
are also recommended for use in the Extra-Amazon
area [10].
The objective of this study was to estimate the incre-
mental cost-effectiveness ratio, considering the use of
five commercial RDT brands for malaria, compared with
the conventional diagnosis method by thick smear, for
the year 2010. This is the first cost-effectiveness analysis
for malaria diagnosis in the Extra-Amazon Region and
the first that evaluates five different commercial tests in
Brazil. The information will be a help to decision-makers
with respect to the use of RDTs in the Region.
Methods
Diagnostic strategies evaluated
Five RDTs for diagnostic of new cases of malaria due to
P. falciparum and P. vivax were evaluated in comparison
to the conventional diagnostic strategy – thick smear
microscopy. The RDTs evaluated were: 1) SD Bioline
FK60 (PF/Pan)TM – Bioline; 2) CareStart (Pan)TM - DiaSys;
3) First Response Malaria ComboTM - Premier Medical
Corporation Ltd.; 4) ParascreenTM (Pf/Pan) – Zephyr Bio-
medicals by The Tulip Group; and 5) ICT BinaxNOW
MalariaTM - BinaxNOW.
Decision analytic model
A decision tree was developed to compare five RDTs
with conventional thick smear microscopy as diagnostic
strategies for new cases of malaria in the Extra-Amazon
Region. Figure 1 presents the basic structure of the deci-
sion tree. A hypothetical cohort of all febrile individuals
who had a diagnostic procedure for malaria conducted
in 2010 in the Extra-Amazon Region was simulated,
considering its various probability nodes. All individuals
(100%) presenting with fever to health facilities would
undergo diagnostic test using either microscopy or one
of the five RDTs. They could either have malaria or not,
estimated by the prevalence of malaria in the population
presenting fever and suspected malaria. If the patient
Figure 1 Basic structure of decision tree for the “adequately diagnosed cases”. Notes: RT = Rapid Test; Neg = negative; + = positive; /1 =
adequately diagnosed case; /0 = inadequate diagnosis.
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for malaria, indicating infection due to P. falciparum or
P. vivax - representing a true positive result (sensitivity);
or could result negative (1-sensitivity) representing a
false negative result. If the patient did not have malaria,
the diagnostic test could result negative, representing
a true negative result (specificity); or result positive
(1-specificity) representing a false positive result. While
true positive and true negative results were considered
adequately diagnosed cases, false negatives and false
positives were considered incorrectly diagnosed cases.
These were the terminal nodes of the decision tree
(Figure 1). Cost and epidemiological data were collected
and inserted to populate this decision tree.
In the analytical framework, the cases were followed
up from fever onset until diagnostic results were pro-
vided. The study period was January-December 2010.
The analysis perspective was that of the Brazilian Public
Health System. The outcome considered in the analysis
was adequately diagnosed cases of malaria.
The hypothetical cohort was based on 2,702 valid
registered notifications of investigation into malaria in
the Extra-Amazon Region, for the year 2010. Ten percent
more was added to this number, taken as the wastagerate, making a total of 2,972 diagnostic tests, the number
which became the basis of the decision model and of the
cost calculations.
Costs of malaria diagnosis
Only direct diagnostic costs were considered. All costs
were calculated in Brazilian Reais and converted to U.S
dollars considering the official average exchange rate for
2010 (US$1.00 = R$1.7597) [11].
Cost data were obtained from scientific literature,
official government reports and the reimbursement table
for procedures by the National Health System. The direct
costs of RDTs were obtained from laboratory product
suppliers and from the Ministry of Health.
Costs considered for microscopy diagnostic strategy
included: thick smear microscopy with consumables,
supplies and equipment costs (microscope purchase and
maintenance). Costs considered for RDT diagnostic
strategies included the direct cost of the RDT and gloves.
The RDT costs were varied at 20% above and below the
base-case value, to compose the intervals.
Consumables and supply costs for microscopy were
aggregated into one estimated cost measure of conduct-
ing a single thick smear procedure. In the base-case, the
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Macauley in Brazil [6] based on costs of all used micro-
scopy supplies through a passive case detection diagnosis
strategy. Upper level variation for sensitivity analysis also
considered Macauley’s [6] estimates through a passive
plus active case detection diagnosis strategy. As these
costs were estimated for 2001, they were adjusted for
inflation considering the Consumer Price Index for 2010
[12]. Lower level variations around the base-case were
estimated for sensitivity analysis using micro-costing
techniques in which the cost of individual consumables
required to perform one thick smear procedure were
estimated. Costing method and information sources for
micro-costing were published by Oliveira and co-workers
(2010) [13] and adjusted for inflation considering the
Consumer Price Index [12].
The costs of two consultations in a specialized public
outpatient service were included for all strategies, con-
sidered the recommended minimum for carrying out the
diagnosis.
Equipment costs
The costs of the microscopes were obtained from the
Ministry of Health, based on purchase in 2008, and their
maintenance costs were obtained from Oliveira and co-
workers (2010) [13]; these costs were also adjusted for
inflation considering the Consumer Price Index. It was
assumed that there was one microscope available for
each professional’s use and an annual maintenance cost
for each piece of equipment. The cost of the microscope
was averaged over the year based on a 5% depreciation
rate and a 15-year average lifespan [14,15].
To estimate the cost of the microscopes and their
maintenance, per slide examined, two different costing
methods were carried out. The first, called Cost 1, con-
sidered the information obtained from the five states
that reported 50% of the cases in 2010 (SP, ES, MG, GO
and DF) and assumed that a microscope was bought for
each reference center for the diagnosis of malaria in that
states; the final cost was divided by the number of slides
examined and 10% was added for wasted tests. The
microscope and maintenances costs per slide in the five
states were thus assumed as the standard for the whole
Extra-Amazon Region. This form of costing presupposed
the use of microscopes exclusively for malaria.
The second costing method, Cost 2, was based on the
WHO [16] considering the workload of professionals
who diagnose malaria. In this method, costs of equip-
ment and its maintenance were assumed to be shared
with other health programmes, and they were estimated
using the WHO’s parameters that determine the number
of microscopy diagnostic tests performed per hour at
four different levels of malaria prevalence [16], consider-
ing for the study area the parameters that are estimatedfor low-prevalence areas. The total costs for each diag-
nostic strategy for these items represented the average
costs in the study area weighted by malaria prevalence.
Costs of salaries, training courses, transportation,
quality control procedures, construction and mainten-
ance of laboratories were not considered. Table 1 pre-
sents cost components and their respective unit costs
for microscopy and the five RDT diagnoses.
Epidemiological parameters
The epidemiological parameters included in the analytic
model were prevalence of malaria, proportion of malaria
cases due to P. vivax and P. falciparum species, and esti-
mates of sensitivity and specificity of diagnostic techni-
ques for both P. vivax and P. falciparum infections
(Table 2). Secondary sources of epidemiologic data were
the scientific literature (Medline, Lilacs and SciElo data-
bases), and the National Malaria Surveillance Informa-
tion System of the Brazilian Ministry of Health [4].
Accuracy studies for the five RDTs were considered
only if they used microscopy as the gold standard, and
accuracy studies of thick smear microscopy were consid-
ered only if they used polymerase chain reaction as the
gold standard [17-20]. Quality of published accuracy
studies was assessed considering 12 criteria of the Quality
Assessment of Diagnostic Accuracy Studies (QUADAS)
instrument [21] and three additional criteria judged
relevant: socio-demographic characteristics of patients,
confidence interval and the sampling method proposed
by the Standards for Reporting Studies of Diagnostic
Accuracy (STARD) [22].
Fifteen scientific articles were selected as sources for
the values used in the base-case and in the variation of
accuracy estimates for the diagnostic methods studied
(Table 2) [17-20,23-33].
For the epidemiological parameters related to the
probability of malaria and its presentation, the intervals
of variation were constructed with 20% above and below
the base-case value (Table 2).
Cost, cost-effectiveness and sensitivity analysis
Total costs accrued for malaria diagnosis during the
study period were estimated for each diagnostic strategy,
considering the total number of tests performed during
the study period plus 10% (n = 2.972). Incremental cost-
effectiveness ratio (ICER) was calculated considering
the incremental cost needed to adequately diagnose one
individual with suspected malaria using a RDT as
opposed to microscopy. To examine the variability of
the cost-effectiveness ratios, one-way sensitivity analysis
to investigate the effect of parameter values was con-
ducted. Cost parameters for microscopy and RDT diagno-
sis were varied, as were malaria prevalence and accuracy
estimates for each diagnostic method. Parameter values
Table 1 Cost components and unit costs considered for malaria diagnosis
Items Unit cost for base-case
analysis (US$)




Thick smear – one exam (1) 1.34 0.28 – 2.06 Base-case: Macauley, 2005
Variation: Macauley, 2005 and de Oliveira et al.,
2010, based on IEC/SVS/MS. (2)
SD Bioline FK60 (PF/Pan)™ - one test 0.93 0.74 – 1.12 Base-case: Ministry of Health
Variation: 20% above and below the base-case.
CareStart (Pan)™ - one test 3.86 3.09 – 4.64 Base-case: Laboratory supplier
Variation: 20% above and below the base-case
First Response Malaria Combo™ - one test 0.82 0.66 – 0.99 Base-case: Laboratory supplier
Variation: 20% above and below the base-case
Parascreen™ (Pf/Pan) – one test 0.92 0.74 – 1.10 Base-case: Laboratory supplier
Variation: 20% above and below the base-case.
BinaxNOW Malaria™ - one test 4.93 3.94 – 5.92 Base-case: Laboratory supplier
Variation: 20% above and below the base-case.
Latex gloves to use with RDT (3) 0.03 0.07 Base-case and variation: de Oliveira e et al., 2010.
Health services
Consultation in a specialized public
outpatient service
11.37 —— National Healthcare System reimbursement table.
Equipment
Microscope – one unit - annual value 432.71(4) 292.19(5) Base-case and variation: Ministry of Health.
Microscope maintenance – one annual
maintenance
54.10(6) 43.53 – 64.92 Base-case and variation: de Oliveira et al., 2010,
based on IEC/SVS/MS. (2)
Variation: 20% above and below the base-case.
Extra-Amazon Region, Brazil, 2010.
Notes:
(1) Corresponds to the individual cost of one test considering the following inputs: glass slide, Giemsa and other dyes.
(all the components for staining), immersion oil, lancet, cotton-wool, alcohol and gloves.
(2) The Malaria Laboratory of the Instituto Evandro Chagas (IEC), of SVS/MS, provided the individual costs of each input for carrying out staining and reading of the
slide; costs were calculated for one test produced.
(3) Latex gloves – part of the cost of each RDT.
(4) Annual cost of microscopy for 15 years. The cost of one unit was the basis for obtaining the cost per slide examined, for two different costing methods.
(5) Annual cost of microscopy for 30 years. The cost of one unit was the basis for obtaining the cost per slide examined, for two different costing methods.
(6) The cost of maintenance was the basis for obtaining the cost per slide examined for two different costing methods.
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of costs (Table 1) and epidemiologic parameters (Table 2)
considered in the analysis and their respective sources of
information are presented. TreeAge ProW software was
used to build the decision model and for cost-effectiveness
and sensitivity analyses [34].
Ethical issues
This study was a hypothetical model. It was developed
with secondary and not nominal data, not doing experi-
ments in human begins. Conclusions will help to provide
benefits to population at risk of malaria transmission.
Results
Two cost-effectiveness analyses were produced, based on
the two costing methods and relative to the costs per
microscope test and of the maintenance of microscopes.
To identify the analyses, they were labeled “exclusivemicroscope” – for the Cost 1 method that does not take
into account the workload with malaria, assuming that
the microscopes are used exclusively to diagnose the
disease – and “shared microscope” – for the Cost 2
method that is weighted by the workload of health
professionals working with malaria.
The results of cost-effectiveness analysis of the micros-
copy strategies and of each of the five RDTs analysed,
for the outcome “adequately diagnosed cases” with Cost
1 are presented in Table 3 and results with Cost 2 are
presented in Table 4. Both analyses (Tables 3 and 4) used
the cheapest strategy, the RDT First Response Malaria
ComboTM, as the baseline with which other strategies
were firstly compared. To Cost 1, inicial comparisons
of Parascreen, SD Bioline FK60 and CareStart were
made to First Response Malaria Combo, the cheapest
strategy; ICT BinaxNOW and Microscopy were com-
pared to CareStart conforming sequence presented in






Prevalence of malaria among febrile patients
seeking diagnosis
0.467 0.560 e 0.373 Base-case: Ministry of Health
Variation: 20% above and below the base-case.
Proportion of malaria cases due to Plasmodium
vivax
0.713 0.856-0.570 Base-case: Ministry of Health
Variation: 20% above and below the base-case.
Proportion of malaria cases due to Plasmodium
falciparum
0.287 0.344-0.230 Base-case: Ministry of Health
Variation: 20% above and below the base-case.
Sensitivity of microscopy for Plasmodium vivax 0.950 0.717 Base-case: Ohrt e et al., 2002 - Variation: Andrade e et al.,
2010.
Specificity of microscopy for Plasmodium vivax 1.000 0.950 Base-case: Haghdoost et al., 2006; Variation: Haghdoost
et al., 2006.
Sensitivity of microscopy for Plasmodium
falciparum
0.976 0.757 Base-case: Alam et al., 2011; Variation: Andrade et al.,
2010.
Specificity of microscopy for Plasmodium
falciparum
1.000 0.932 Base-case: Andrade et al., 2010; Variation: Alam e et al.,
2011;
Sensitivity of CareStart™ for Plasmodium vivax 0.953 0.711-1.000 Base-case: Mekonnen et al., 2010; Variation: Upper value:
Sharew e et al., 2009. Lower value: Ashley e et al., 2009.
Specificity of CareStart™ for Plasmodium vivax 1.000 0.919 Base-case: Mekonnen e et al., 2010; Variation: Ratsimbasoa
e et al., 2007.
Sensitivity of CareStart™ for Plasmodium
falciparum
0.964 0.854-1.000 Base-case: Mekonnen et al., 2010; Variation: Upper value:
Sharew e et al., 2009. Lower value: Ashley e et al., 2009.
Specificity of CareStart™ for Plasmodium
falciparum
1.000 0.881 Base-case: Mekonnen et al., 2010; Variation: Ratsimbasoa e
et al., 2007.
Sensitivity of First Response Malaria Combo™
for Plasmodium vivax
0.842 0.721-0.925 Base-case: Singh et al., 2010; Variation: Singh et al., 2010
Specificity of First Response Malaria Combo™
for Plasmodium vivax
0.940 0.900 – 0.982 Base-case: Bharti e et al., 2008; Variation: Upper value:
Singh et al., 2010. Lower value: Bharti et al., 2008.
Sensitivity of First Response Malaria Combo™
for Plasmodium falciparum
0.960 0.880-0.990 Base-case: Bharti e et al., 2008; Variation: Bharti e et al.,
2008.
Specificity of First Response Malaria Combo™
for Plasmodium falciparum
0.950 0.756-0.970 Base-case: Bharti et al.,2008; Variation: Upper value: Bharti
et al., 2008. Lower value: Singh et al., 2010.
Sensitivity of Parascreen™ for Plasmodium vivax 0.772 0.642-0.873 Base-case: Singh e et al., 2010; Variation: Singh e et al.,
2010.
Specificity of Parascreen™ for Plasmodium vivax 0.981 0.959-0.993 Base-case: Singh et al., 2010; Variation: Singh et al., 2010.
Sensitivity of Parascreen™ for Plasmodium
falciparum
0.940 0.885-0.974 Base-case: Singh et al., 2010; Variation: Singh et al., 2010.
Specificity of Parascreen™ for Plasmodium
falciparum
0.720 0.658-0.776 Base-case: Singh et al., 2010; Variation: Singh et al., 2010.
Sensitivity of BinaxNOW™ for Plasmodium vivax 0.873 0.729-0.930 Base-case: Wongsrichanalai et al., 2003; Variation: Upper
value: Wongsrichanalai et al., 2003. Lower value: Pabón
et al., 2007.
Specificity of BinaxNOW™ for Plasmodium vivax 0.977 0.995-1.00 Base-case: Wongsrichanalai et al., 2003; Variation: Pabón e
et al., 2007.
Sensitivity of BinaxNOW™ for Plasmodium
falciparum
1.000 0.520-0.960 Base-case: Wongsrichanalai et al., 2003; Variation: Upper
value: Farcas et al., 2003. Lower value: Pabón et al., 2007.
Specificity of BinaxNOW™ for Plasmodium
falciparum
0.962 0.920-0.980 Base-case: Wongsrichanalai et al., 2003; Variation:
Wongsrichanalai et al., 2003.
Sensitivity of SD Bioline FK60 (PF/Pan)™ for
Plasmodium vivax
0.710 0.636(0.424-0.815) Base-case: Vas Dev, 2004. Variation: Ratsimbasoa, 2008 (1)
Specificity of SD Bioline FK60 (PF/Pan)™ for
Plasmodium vivax
1.000 0.989(0.946-0.999) Base-case: Vas Dev, 2004. Variation: Ratsimbasoa, 2008
Sensitivity of SD Bioline FK60 (PF/Pan)™ for
Plasmodium falciparum
1.000 0.929 (0.889-0.971) Base-case: Vas Dev, 2004. Variation: Ratsimbasoa, 2008
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Table 2 Epidemiological parameters considered in the analytic model (Continued)
Specificity of SD Bioline FK60 (PF/Pan)™
for Plasmodium falciparum
1.000 0.989 (0.946-0.999) Caso-base: Vas Dev, 2004. Variação: Ratsimbasoa, 2008
Extra-Amazon Region, Brazil, 2010.
Note: (1) Exception: The article by Ratsimbasoa (2008) used a combination of PCR and thick smear as the gold standard.
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SD Bioline FK60 and Microscopy were made to First
Response Malaria Combo, the cheapest strategy; Care
`Start ICT and BinaxNOW were compared to Micros-
copy conforming sequence presented in Table 4.
In the results shown in Table 3, the tests ParascreenTM
and SD Bioline FK60TM were dominated by the First
Response Malaria ComboTM. The ICT BinaxNOWTM test
was dominated by CareStartTM. The RDT CareStartTM
was the most cost-effective diagnostic strategy. Micro-
scopy was the most expensive and most effective, with
an additional case adequately diagnosed by microscopy
costing US$ 35,550.00 in relation to CareStartTM.
When the cost of microscopes and their maintenance
was used weighted by workload with malaria (cost 2),
the base-case result is exactly the opposite, making mi-
croscopy an extremely cost-effective strategy compared
to First Response Malaria ComboTM. All the other RDTs
were dominated (Table 4).
Sensitivity analysis
In sensitivity analysis, cost-effectiveness ratios were sen-
sitive to few parameters. Using basic costs of RDT, only
two technologies - ICT BinaxNOWTM and CareStartTM-
have a higher individual cost than the cost estimated for
microscopy, the standard technology used in the public
health system. One-way sensitivity analysis of the costs
of each of these two RDT was carried out for the two
analytic models. Both for the analytic model with exclu-
sive use of microscopy (Cost 1) and for the shared
microscopy (Cost 2) the reduction of 20% in the cost of
each of the cited tests, in accordance with the intervals
considered, did not alter the results for the base-case.Table 3 Results of the cost-effectiveness analysis of strategies
adequately diagnosed case




First Response Malaria Combo 12.22 ____
Parascreen 12.32 0.10
SD Bioline FK60 12.33 0.11
CareStart 15.26 3.04
ICT BinaxNOW 16.33 1.07
Microscopy 36.59 21.33
Extra-Amazon Region, Brazil, 2010.
Note: (1) Inicial comparisons of Parascreen, SD Bioline FK60 and CareStart were mad
and Microscopy were compared to CareStart.In the one-way sensitivity analysis relative to the model
with exclusive microscopy (Cost 1 – Table 3), when the
pre-test probability (prevalence) was reduced to 37.30%,
the RDT SD BiolineTM became the most cost-effective
strategy, with ICER of US$ 21.59 per adequately diag-
nosed case, in comparison with First Response Malaria
ComboTM.
In the sensitivity analysis for the shared microscope
model (Cost 2), microscopy continued to be cost-effective,
even with reductions in its accuracy (Table 5), according
to the values from the sources, except when the sensi-
tivity to P. vivax varied to 0.7170; in this situation it
was dominated by First Response Malaria ComboTM
(Table 5). At the same model, when the estimated
sensitivity for SD Bioline FK60TM for P.vivax reached
the maximum value found in the scientific literature -
81.50% - , this RDT became extremely cost-effective, in
relation to the cheapest strategy, with an ICER of only
US$ 3.98 per adequately diagnosed case. In the same
analysis, microscopy was also cost-effective compared
to SD Bioline, with an ICER of US$ 10.62 per adequately
diagnosed case.
Introducing a “proxy” measurement into the analytic
model with shared microscopy (Cost 2) for individual
access to the diagnosis, assuming a probability of 100%
of access for a public health system user to the RDT and,
hypothetically, of 85% of access to microscopy – due to
its technical requirements and the relocation needed to
reach places where the test is carried out – microscopy
saw its effectiveness reduced and was dominated by the
RDT CareStartTM. CareStartTM, in this variation, pre-
sented ICER per diagnosed case of US$ 44.75 compared











e with First Response Malaria Combo, the cheapest strategy. ICT BinaxNOW
Table 4 Results of the cost-effectiveness analysis of strategies for malaria diagnosis with shared-use microscopy, per
adequately diagnosed case








First Response Malaria Combo 12.22 ____ 0.9116 ____
Parascreen 12.32 0.10 0.8660 −0.0456 (Dominated)
SD Bioline FK60 12.33 0.11 0.9034 −0.0082 (Dominated)
Microscopy 12.77 0.55 0.9801 0.0685 8.03
CareStart 15.26 2.49 0.9795 −0.0006 (Dominated)
ICT BinaxNOW 16.33 3.56 0.9432 −0.0363 (Dominated)
Extra-Amazon Region, Brazil, 2010.
Note: (1) Inicial comparisons of Parascreen, SD Bioline FK60 and Microscopy were made with First Response Malaria Combo, the cheapest strategy. CareStart and
ICT BinaxNOW Microscopy were compared to Microscopy.
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A review of 55 studies of the costs and 43 studies of
the cost-effectiveness of malaria interventions revealed
that most studies dealing with economic evaluations
for malaria diagnostic are carried out in Africa, with
only 4% of them taking place in South America [35].
This is the first cost-effectiveness study in Brazil that
evaluated more than one commercial RDT brand simul-
taneously, and the first that took place outside the Amazon
Region.
When making informed decisions on RDT introduc-
tion, as recommended for the Brazilian Extra-Amazon
Region, a product with high accuracy should be selected,
as recommended by the WHO [8]. Although various
different RDTs are available, they can differ significantly
in sensitivity and specificity values.
In Brazil, there are two published economic evaluation
studies of malaria diagnosis; both were conducted in the
Amazon Region [7,13]. The first was a cost-minimization
analysis conducted in rural Brazil, which demonstrated
that the RDT ParaSight-FW was more cost-effective than
microscopy, mainly due to significantly lower transporta-
tion costs when using RDTs [7].Table 5 Results of the one-way sensitivity analysis for the
model with shared-use microscopy, considering







ratio (US$) of microscopy
compared to First Response
Malaria Combo
Sensibilidade – P. vivax 0.7170 (Dominated)
0.8585 14.47
Sensibilidade – P. falciparum 0.7570 14.06
0.8785 9.93
Especificidade – P. vivax 0.9500 11.12
Especificidade – P. falciparum 0.0320 9.48
Extra-Amazon Region, Brazil, 2010.
Note: * Only variation values in which changes in ICER occurred are presented.The second Brazilian study was by Oliveira and
co-workers [13] who evaluated a commercial RDT
brand, OptiMalW, in Amazonian areas not covered by a
microscope-equipped laboratory. The study concluded
that the RDT would be more cost-effective in these areas
if the accuracy of microscopy practiced in the field was
lower than values assumed in the base-case.
Lubell and co-workers [36] and Chanda and co-workers
[37] also demonstrated that RDT was cost-effective when
compared to microscopy, in African countries, in settings
where microscopy accuracy was low. Lubell and co-
workers [36], Chanda and co-workers [37], Shillcutt and
co-workers [38], and Rolland and co-workers [39] pointed
to the need for alternative malaria diagnostic methods in
studies conducted in Africa, where low accuracy of diag-
nosis was observed.
In recent years, new cost-effectiveness studies for
malaria diagnosis have been carried out in African
countries. The differing epidemiological situations and
various methodologies used in these studies prevent fur-
ther comparisons with the current evaluation, but it can
be noted that the published African studies concluded
that RDTs are more cost-effective in high and low trans-
mission situations in Uganda [40], in association with the
use of artemisinin-based drugs in Senegal [41] in areas of
Mozambique [42] and of Ethiopia [43] when compared
to presumptive treatment or to microscopy. In the African
situations, the use of RDTs leads to rational use of medica-
tion, avoiding the waste that can occur with presumptive
treatment.
In the present study, when assuming the use of
microscopy laboratories exclusively for malaria diagnosis,
this strategy was not cost-effective, since an additional
microscopy-diagnosed case was estimated at over 35,000
dollars comparing to CareStartTM, due to the vast differ-
ence in the cost of microscopy compared to other strat-
egies if equipment is only used for malaria diagnosis.
It should be noted that this is more than three times
the Brazilian per capita Gross Domestic Product for the
year 2010, which was US$ 10,806.39 [44]. Due to the
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exclusive use of equipment and structures for thick
smear test, not sharing with other programmes, would
be the worst possible use of resources. However, in the
cost method that weighted malaria workload for the
professionals in the Extra-Amazon area, microscopy
presented a fairly rational use of resources, due to its
low cost and high effectiveness.
It is important to stress that in analyses presented in
Tables 3 and 4, the supposition was that the strategies
would use the same health service organization. Thus,
without considering the possibility of expanded access to
diagnosis with the introduction of a RDT, and assuming
that microscopy equipment was shared with other health
programmes, the thick smear test would be the most cost-
effective strategy (Table 4). If public health services pro-
vided easier access to RDTs in the Brazilian states of
the Extra-Amazon Region, differentiating the probability
of access to RDTs from access to microscopy, then the
RDT CareStartTM would be more cost-effective, even as-
suming shared use of microscopy with other programmes
and maintaining assumptions of the model under study.
SD Bioline FK60TM is the RDT technology that the
Brazilian Ministry of Health has bought in recent years.
The search for data on its accuracy, however, was not
very efficient. Various RDTs are produced by the Bioline
laboratory, and there are few scientific articles that
clarify the use of the same test used in Brazil: the FK 60
with enzymes HRP2 and pLDH. As a RDT used in
Brazil, it should be thoroughly evaluated in terms of its
accuracy, so that the country has its own set of valid
results that can be applied in cost-effectiveness analyses
and in other studies that aid decision-making. It would
also be very interesting and helpful to know the accur-
acy levels of microscopy practiced in the Extra-Amazon
Region, especially considering the low number of slides
examined, which can contribute to loss of experience in
the diagnostic exam.
It’s important to note that, differently from Amazon
Region, the diagnostic in Extra-Amazon Region, either
with rapid tests or microscopy, involves the same pro-
fessionals in its execution. Thus there are not relevant
differences in other costs as salaries or transportation,
being the cost of equipments and its maintenance and
the direct cost of exams the most important differences
between the strategies. The analysis didn’t extend to
treatment of patients because of the lacking information
about the treatment of non-malaria cases, which pre-
vents a complete analysis of the economic consequences
of misclassified cases and because of the greater interest
in the costs of diagnosis itself to help decisions about the
use of rapid tests in Brazil. As it has been noted in other
settings of malaria transmission [38], improving data on
treatment of non malaria cases in Brazil is urgentlyneeded to allow the expansion of economic analysis for
this disease.
Conclusion
The analysis of cost-effectiveness of malaria diagnosis
technologies in the Brazilian Extra-Amazon Region
depends on the exclusive or shared use of the “micros-
copy” strategy. Following the assumptions of this study,
shared microscopy would be the most cost-effective
strategy of the six technologies evaluated. However, if used
exclusively for diagnosing malaria, microscopy would be
the worst use of resources. Access to the diagnosis is
also an important factor in evaluating cost-effectiveness
of strategies. Microscopy would not be the most cost-
effective strategy, even when structure is shared with
other programmes, when the probability of a patient
having access to it was reduced and the probability of
having access to RDTs was 100%. Under these circum-
stances, the RDT CareStartTM would be the most cost-
effective strategy. This discussion is very important for
managers to consider if RDTs are introduced into these
areas to broaden access to diagnosis.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
MRFO conceived the study, participated in the design of the study,
performed the analysis and drafted the manuscript. SPG conceived the study
and participated in its analysis. HMP conceived the study and participated in
its analysis. GASR coordinated the study and participated in its design and
analysis. All authors read and approved the final manuscript.
Acknowledgements
Dr. José Lázaro Ladislau and Dr. Ana Carolina Santelli - National Malaria
Control Programme Managers/Ministry of Health - by substantial
contributions to collect epidemiologic and costs data. Ministry of Health and
CNPq – Conselho Nacional de Desenvolvimento Científico e Tecnológico,
Brazil, by financial support (CNPq process number 559376/2009-0).
Author details
1School of Medicine, University of Brasília, Brasilia, Brazil. 2National Institute
for Science and Technology for Health Technology Assessment (IATS/CNPq),
Porto Alegre, Rio Grande do Sul, Brazil. 3Ministry of Health, Brasilia, Brazil.
4State Secretariat of Health, Brasilia, Brazil.
Received: 11 July 2012 Accepted: 20 November 2012
Published: 23 November 2012
References
1. Ministério da Saúde. Secretaria de Vigilância em Saúde: Vigilância em Saúde.
Situação epidemiológica da malária no Brasil - folder. Brasília: Ministério da
Saúde; 2008.
2. Loiola CC, da Silva CJ, Tauil PL: Malaria control in Brazil: 1965 to 2001. Rev
Panam Salud Publica 2002, 11:235–244.
3. Tauil PL: Comments on the epidemiology and control of malaria in Brazil.
Mem Inst Oswaldo Cruz 1988, 81(Suppl. II):39–41.
4. Ministério da Saúde. DATASUS: Sistema de Informação de Agravos de
Notificação; acessado em 2010 para informações do mesmo ano]. Available
at: http://dtr2004 saude.gov.br/sinanweb/index php 2010.
5. Moody A: Rapid diagnostic tests for malaria parasites. Clin Microbiol Rev
2002, 15:66–78.
6. Macauley C: Aggressive active case detection: a malaria control strategy
based on the Brazilian model. Soc Sci Med 2005, 60:563–573.
de Oliveira et al. Malaria Journal 2012, 11:390 Page 10 of 10
http://www.malariajournal.com/content/11/1/3907. Pang LW, Piovesan-Alves F: Economic advantage of a community-based
malaria management program in the Brazilian Amazon. AmJTrop Med
Hyg 2001, 65:883–886.
8. World Health Organization: Malaria diagnosis - new perspectives. Geneva:
WHO; 2000.
9. Ministério da Saúde.Secretaria de Vigilância em Saúde: Guia de Vigilância
Epidemiológica. In Normas e Manuais Técnicos. 6ath edition. Edited by Série
A. Brasília: Ministério da Saúde; 2006.
10. Ministério da Saúde.Secretaria de Vigilância em Saúde: Guia de Vigilância
Epidemiológica. In Normas e Manuais Técnicos. 7ath edition. Edited by Série
A. Brasília: Ministério da Saúde; 2010.
11. Banco Central do Brasil: Serviços ao Cidadão. Taxas de Câmbio. acessado em
2011 para informações de 2010. Available at: http://www4.bcb.gov br/pec/
taxas/port/PtaxRPesq asp?idpai=TXCOTACAO 2011.
12. Ministério do Planejamento, Orçamento e Gestão. IBGE: Sistema Nacional de
Índices de Preços ao Consumidor - SNIPC. acessado em dezembro de 2011,
para informações do mesmo ano. Available at http://www.sidra.ibge.govbr/
snipc/default asp 2011.
13. de Oliveira MR, de Castro GA, Toscano CM: Cost effectiveness of OptiMal
(R) rapid diagnostic test for malaria in remote areas of the Amazon
Region. Brazil. Malar J 2010, 9:277.
14. Fernando SD, Karunaweera ND, Fernando WP, Attanayake N,
Wickremasinghe AR: A cost analysis of the use of the rapid, whole-blood,
immunochromatographic P.f/P.v assay for the diagnosis of Plasmodium
vivax malaria in a rural area of Sri Lanka. Ann Trop Med Parasitol
2004, 98:5–13.
15. Phillips M, Mills A, Dye C: Directrices para el analisis del costo-eficacia de la
lucha antivectorial. Serie de Directrices CEOM 3. Ginebra: OMS; 1996.
16. World Health Organization - Regional office for the Western Pacific: Malaria
Light Microscopy - creating a culture of quality; accessed in March 2008.
Available at http://whqlibdoc.who.int/wpro/2005/RS_2005_GE_03(MAA)
_eng pdf 2005.
17. Ohrt C, Purnomo, Sutamihardja MA, Tang D, Kain KC: Impact of microscopy
error on estimates of protective efficacy in malaria-prevention trials.
J Infect Dis 2002, 186:540–546.
18. Andrade BB, Reis-Filho A, Barros AM, Souza-Neto SM, Nogueira LL, Fukutani
KF, Camargo EP, Camargo LMA, Barral A, Duarte A, Barral-Neto M: Towards
a precise test for malaria diagnosis in the Brazilian Amazon: comparison
among field microscopy, a rapid diagnostic test, nested PCR, and a
computational expert system based on artificial neural networks.
Malar J 2010, 9:117.
19. Haghdoost AA, Mazhari S, Bahadini K: Comparing the results of light
microscopy with the results of PCR method in the diagnosis of
plasmodium vivax. J Vector Borne Dis 2006, 43:53–57.
20. Alam MS, Mohon AN, Mustafa S, Khan WA, Islam N, Karim MJ, Khanum H,
Sullivan DJ Jr, Haque R: Real-time PCR assay and rapid diagnostic tests for
the diagnosis of clinically suspected malaria patients in Bangladesh.
Malar J 2011, 10:175.
21. Whiting PF, Weswood ME, Rutjes AW, Reitsma JB, Bossuyt PN, Kleijnen J:
Evaluation of QUADAS, a tool for the quality assessment of diagnostic
accuracy studies. BMC Med Res Methodol 2006, 6:9.
22. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM,
Moher D, Rennie D, de VET HCW, Lijmer JG: The STARD statement for
reporting studies of diagnostic accuracy: explanation and elaboration.
Clin Chem 2003, 49:7–18.
23. Ashley EA, Touabi M, Ahrer M, Hutagalung R, Htun K, Luchavez J, Dureza C,
Proux S, Leimanis M, Lwin MM, Koscalova A, Comte E, Hamade P, Page AL,
Nosten F, Guerin PJ: Evaluation of three parasite lactate dehydrogenase-
based rapid diagnostic tests for the diagnosis of falciparum and vivax
malaria. Malar J 2009, 8:241.
24. Bharti PK, Silawat N, Singh PP, Singh MP, Shukla M, Chand G, Dash AP,
Singh N: The usefulness of a new rapid diagnostic test, the First
Response Malaria Combo (pLDH/HRP2) card test, for malaria diagnosis in
the forested belt of central India. Malar J 2008, 7:126.
25. Farcas GA, Zhong KJ, Lovegrove FE, Graham CM, Kain KC: Evaluation of the
Binax NOW ICT test versus polymerase chain reaction and microscopy
for the detection of malaria in returned travelers. AmJTrop Med Hyg 2003,
69:589–592.
26. Mekonnen Z, Ali S, Belay G, Suleman S, Chatterjee S: Evaluation of the
performance of CareStart Malaria Pf/Pv Combo rapid diagnostic test forthe diagnosis of malaria in Jimma, southwestern Ethiopia. Acta Trop 2010,
113:285–288.
27. Pabon A, Alvarez G, Yanez J, Cespedes C, Rodriguez Y, Restrepo A, Blair S:
Evaluation of ICT malaria immunochromatographic Binax NOW ICT P.f/P.
v test for rapid diagnosis of malaria in a Colombian endemic area.
Biomedica 2007, 27:225–235.
28. Ratsimbasoa A, Fanazava L, Radrianjafy R, Ramilijaona J, Rafanomezantsoa H,
Menard D: Evaluation of two new immunochromatographic assays for
diagnosis of malaria. AmJTrop Med Hyg 2008, 79:670–672.
29. Sharew B, Legesse M, Animut A, Jima D, Medhin G, Erko B: Evaluation of
the performance of CareStart Malaria Pf/Pv Combo and Paracheck Pf
tests for the diagnosis of malaria in Wondo Genet, southern Ethiopia.
Acta Trop 2009, 111:321–324.
30. Singh N, Shukla MM, Shukla MK, Mehra RK, Sharma S, Bharti PK, Singh MP,
Singh A, Gunasekar A: Field and laboratory comparative evaluation of
rapid malaria diagnostic tests versus traditional and molecular
techniques in India. Malar J 2010, 9:191.
31. Wongsrichanalai C, Arevalo I, Laoboonchai A, Yingyuen K, Miller RS, Magill
AJ, Forney JR, Gasser RA Jr: Rapid diagnostic devices for malaria: field
evaluation of a new prototype immunochromatographic assay for the
detection of Plasmodium falciparum and non-falciparum Plasmodium.
AmJTrop Med Hyg 2003, 69:26–30.
32. Ratsimbasoa A, Randriamanantena A, Raherinjafy R, Rasoarilalao N, Menard D:
Which malaria rapid test for Madagascar? Field and laboratory evaluation
of three tests and expert microscopy of samples from suspected malaria
patients in Madagascar. AmJTrop Med Hyg 2007, 76:481–485.
33. Dev V: Relative utility of dipsticks for diagnosis of malaria in
mesoendemic area for Plasmodium falciparum and P. vivax in
northeastern India. Vector Borne Zoonotic Dis 2004, 4:123–130.
34. Tree Age Pro [software]: Version 2005 - release 1.0. Williamstown (MA):
TreeAge Software Inc; 2005.
35. White MT, Conteh L, Cibulskis R, Ghani AC: Costs and cost-effectiveness of
malaria control interventions-a systematic review. Malar J 2011, 10:337.
36. Lubell Y, Reyburn H, Mbakilwa H, Mwangi R, Chonya K, Whitty CJ, Mills A:
The cost-effectiveness of parasitologic diagnosis for malaria-suspected
patients in an era of combination therapy. AmJTrop Med Hyg 2007,
77(6 Suppl):128–132.
37. Chanda P, Castillo-Riquelme M, Masiye F: Cost-effectiveness analysis of the
available strategies for diagnosing malaria in outpatient clinics in
Zambia. Cost Eff Resour Alloc 2009, 7:5–16.
38. Shillcutt S, Morel C, Goodman C, Coleman P, Bell D, Whitty JM, Mills A: Cost-
effectiveness of malaria diagnostic methods in sub-Saharan Africa in an
era of combination therapy. Bull WHO 2008, 86:101–110.
39. Rolland E, Checchi F, Pinoges L, Balkan S, Guthmann JP, Guerin PJ:
Operational response to malaria epidemics: are rapid diagnostic tests
cost-effective? Trop Med Int Health 2006, 11:398–408.
40. Batwala V, Magnussen P, Hansen KS, Nuwaha F: Cost-effectiveness of
malaria microscopy and rapid diagnostic tests versus presumptive
diagnosis: implications for malaria control in Uganda. Malar J 2011, 10:372.
41. Ly AB, Tall A, Perry R, Baril L, Badiane A, Faye J, Rogier C, Touré A, Sokhna C,
Trape JF, Michel R: Use of HRP-2-based rapid diagnostic test for
Plasmodium falciparum malaria: assessing accuracy and cost-effectiveness
in the villages of Dielmo and Ndiop. Senegal. Malar J 2010, 9:153.
42. Zikusooka CM, McIntyre D, Barnes KI: Should countries implementing an
artemisinin-based combination malaria treatment policy also introduce
rapid diagnostic tests? Malar J 2008, 7:176.
43. Lemma H, San SM, Lofgren C, Barnabas G: Cost-effectiveness of three
malaria treatment strategies in rural Tigray, Ethiopia where both
Plasmodium falciparum and Plasmodium vivax co-dominate. Cost Eff
Resour Alloc 2011, 9:2.
44. Instituto Brasileiro de Geografia e Estatística – IBGE: Sala de Imprensa -
Indicadores de volume. acessado em fevereiro de 2012 para informações de
2010]. Available at: http://www.ibge.gov.br/home/presidencia/noticias/
noticia_visualiza php?id_noticia=1830&id_pagina= 2012.
doi:10.1186/1475-2875-11-390
Cite this article as: de Oliveira et al.: Cost-effectiveness of diagnostic for
malaria in Extra-Amazon Region, Brazil. Malaria Journal 2012 11:390.
